Many acute lymphoblastic leukemias can be considered as malignant counterparts of cells in the various stages of normal lymphoid development in bone marrow and thymus. T-cell development in the thymus is an ordered and tightly controlled process. Two evolutionary conserved signaling pathways, which were first discovered in Drosophila, control the earliest steps of T-cell development. These are the Notch and Wnt-signaling routes, which both are deregulated in several types of leukemias. In this review we discuss both pathways, with respect to their signaling mechanisms, functions during T-cell development and their roles in development of leukemias, especially T-cell acute lymphoblastic leukemia.
Introduction
It is becoming increasingly clear that most cancers arise from cancer stem cells and follow differentiation pathways that closely resemble the developmental and ontogenetic pathways of normal cells and tissues. This is in particular the case for antigen-specific cells of the immune system, the lymphocytes. There is no other developmental system that has been described to such detail as the differentiation of B lymphocytes in the bone marrow (BM) and of T lymphocytes in the thymus. In order to fully comprehend the malignant processes underlying lymphoid leukemias, the malignant counterpart of lymphocytes, thorough knowledge of normal differentiation pathways is a prerequisite.
T cells develop in the thymus, from BM-derived multipotent progenitors. The 'thymus-seeding' cells encounter molecules that initiate and guide their development: adhesion molecules, cytokines, chemokines and morphogens largely produced by the thymic stroma. These molecules initiate signaling pathways that lead to the activation of transcription factors that change the transcriptional program of a cell. Two exogenously activated signaling pathways that are crucial for thymocyte development and have attracted much attention recently are the Notch and the Wnt-signaling cascades. Both act as molecular switches: the executing transcription factor that is normally bound to the DNA as a transcriptional repressor is converted into an activator. For the Notch pathway, set in motion by ligands of the Delta and Jagged family, this transcription factor is CSL (see section on 'Notch signaling' below). For the Wnt pathway, which is activated by secreted Wnt proteins, these are factors of the Tcf/Lef family, in thymocytes mainly Tcf-1.
Both Notch and Wnt proteins were first identified in Drosophila and named after their effect in the development of the Drosophila wing: heterozygous mutation of Notch resulted in a nicked wing phenotype, 1 whereas the 'wingless' mutation of Wnt dramatically shortened the wing. 2 Attention was attracted to these genes in the mammalian system when it was discovered that both function as proto-oncogenes. Nusse and Varmus 3 discovered the Wnt gene (then termed Int1) as an integration site for mouse mammary-tumor viruses. The first mammalian homologue of the Drosophila Notch gene was identified as TAN1, the fusion partner of the T-cell receptor beta (TCRB) gene in t(7;9) causing T-cell acute lymphoblastic leukemia (T-ALL). 4 Later it was found that both Notch and Wnt signaling play critical roles in normal T-cell development. Both cascades are thought to mediate different processes in the thymus: Notch in differentiation and Wnt in proliferation, although we will show in this review that this is not as clear-cut as assumed. Despite differences in function and their very different molecular mechanisms, many parallels exist for both pathways. Absence of either causes a block at the earliest stages of T-cell development, but both are thought to be important for later stages as well. Interestingly, the two signaling pathways also play a role in hematopoietic stem cell (HSC) self-renewal. Moreover, dysregulated signaling of both cascades is involved in leukemogenesis.
Overview of T-cell development in the thymus
T-cell development takes place in the thymus, a primary lymphoid organ that provides a unique microenvironment for the development of hematopoietic progenitors into mature T cells. 5 In adult mice and humans, these precursor cells are derived from the BM, whereas during fetal development the liver is the principal source. The exact nature of the progenitors is unclear, but some level of multipotency is now commonly accepted. 6, 7 Development into a mature T cell comprises the ordered rearrangement of the different TCR genes and positive and negative selection events that finally lead to the expression of mature TCRab and TCRgd molecules recognizing non-self peptides in context of self-major histocompatibility complex (MHC) or equivalent molecules. These processes take place during a series of discrete phenotypic stages that can be recognized by expression of several key membrane molecules, most notably CD4 and CD8 (Figure 1a) . In both man and mouse, thymocytes are successively CD4
. 8, 9 In the mouse, the DN subset can be further subdivided into four stages:
þ (DN3) and CD44 À CD25 À (DN4). 10 In the human thymus, CD34
þ CD1a À cells correspond to murine DN1 and 2 thymocytes and CD34
þ CD1a þ cells are homologous to DN3 cells 9, 11 ( Figure 1a ). The human DN4 population is hard to distinguish from ISP cells that express low level CD3.
As the numbers of progenitors that enter the thymus are limited, an enormous expansion takes place during the DN1 and DN2 stages of T-cell development 12 ( Figure 1b ). In the DN3 stage, cells stop proliferating and start rearranging the TCRB loci, resulting in a complete TCRb chain during the DN4/ISP stage. 11 When the thymocytes have developed into ISP cells, the functionality of the TCRb chain is tested by expression on the cell surface together with a pre-TCR alpha (pTa) chain, a process called b-selection. 13 Signals emanating from this pre-TCR complex induce the cells first to proliferate and subsequently to initiate TCRA gene rearrangements. The thymocytes now become DP cells. Productive TCRA rearrangements lead to the expression of a TCRab complex on the cell surface, which is then tested for the recognition of self-MHC molecules (positive selection) and absence of reactivity against self-antigens (negative selection). 14 It has been estimated that 95% of developing thymocytes die by apoptosis. 15 The surviving cells become SP thymocytes that mature into either CD4 þ T helper cells or CD8 þ cytotoxic T cells, and migrate to the periphery as naïve recirculating T lymphocytes (Figure 1b) .
The stages of T-cell development take place in different stromal niches in the thymus and are guided by factors produced by thymic epithelial cells (TECs) (Figure 1c ). The proliferation, differentiation and TCR rearrangement steps are tightly regulated by a number of molecular pathways (recently reviewed by Rothenberg and Taghon 16 ) of which Notch and Wnt signaling are perhaps the most conspicious.
Notch signaling in the thymus
The Notch signal transduction pathway, depicted in Figure 2 , is an evolutionary conserved mechanism that regulates cell fate determination during developmental processes. 1 The Notch family of transmembrane receptors consists of four members, named Notch1 to 4. Signaling is initiated when the large extracellular domain of the Notch receptor binds a membranebound ligand on a neighboring cell. The five Notch ligands in mammals are Delta1, 3 and 4 and Jagged1 and 2. The glycosylation status of the Notch receptor can be modified by Fringe proteins, thereby influencing ligand binding. 17 Interaction of Notch with a ligand can induce proteolytic cleavage of Notch, successively by metalloprotease and g-secretase activities, 18, 19 releasing the intracellular part of the protein (intracellular (IC-) Notch). IC-Notch then translocates to the nucleus and binds to the nuclear transcription factor CSL (CBF1¼ c-promoter binding factor in humans, suppressor of hairless in Drosphila, Lag-1 in Caenorhabditis elegans; also called RBP-k in mouse). 20 Binding of IC-Notch to CSL induces the dislocation of co-repressors (coR) such as Mint and Nrarp, and recruitment of co-activators (coA), such as Mastermind (Maml), consequently stimulating the transcription of Notch target genes 20 ( Figure 2 ). The ligands that induce Notch signaling are present on the membrane of stromal cells such as TECs. High levels of Notch ligands Jagged1 and 2 and Delta1 and 4 are expressed in the fetal and adult murine thymus. [21] [22] [23] [24] Expression of Notch ligands has been reported in murine and human BM stroma (Jagged1 25, 26 ), as well as in murine fetal liver (mainly Delta1 and 4 23 ). Notch receptors are expressed by hematopoietic progenitor cells in the BM and fetal liver 22, [27] [28] [29] and by DN thymocytes (predominantly Notch1 and Notch3 24, 29, 30 ). When Notch-expressing hematopoietic progenitor cells enter the thymic microenvironment and interact with Notch ligands on the thymic epithelium, they immediately start expressing The earliest thymocytes enter the thymus at the cortico-medullary junction and migrate to the subcapsular zone. As they mature, they pass through the cortex and the medulla.
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Notch target genes. 22 These Notch signals are essential for the induction of a T-cell fate in progenitor cells. This was first demonstrated in mice in which the NOTCH1 gene was conditionally deleted, resulting in a complete block in T-cell development at the DN1 stage 31 and the emergence of ectopic B-cell development in the thymus. 32 These effects are likely mediated by Notch1 signaling through CSL, as CSL-deficient mice display a phenotype similar to Notch1-deficient mice. 33 Several reports suggest alternative Notch-signaling pathways that are CSL-independent and may involve Deltex as an effector protein, 34 but their importance for T-cell development is not yet known. While inhibition of Notch signaling blocks T-cell development, BM reconstitution of mice with cells transduced with IC-Notch instructed a T-cell fate in BM progenitors and inhibited B-cell development. 35 Similar results were obtained when mice were transplanted with human hematopoietic progenitors overexpressing IC-Notch1 or IC-Notch4. 27, 36 The expression of the different Notch ligands and their receptors in a stage-and tissue-specific manner raises the possibility of a unique function for each ligand. 24 However, the mechanisms by which specific ligands induce different cellular fates remain unclear. Transplantation of mice with progenitors overexpressing Delta1 or 4 phenocopied the effect of overexpression of IC-Notch: DP cells emerged in the BM. 37, 38 In vitro, this phenomenon can be mimicked using BM-derived stromal cell lines (e.g. S17 or OP9) which otherwise promote myeloid and B-cell development of hematopoietic progenitor cells. Forced expression of Delta1 in these stromal cell lines induces murine and human progenitor cells to develop into T cells, in some studies up to DP and SP stages. [39] [40] [41] [42] The striking T-cell generating effect of Delta could not be reproduced by expression of Jagged in stroma cell lines, 39 although Jagged, in another study, did inhibit development into B cells. 41 Furthermore, ab-lineage T-cell development was normal in Jagged2-deficient mice. 43 Signals induced by Jagged may be involved in promoting NK cell or TCRgd þ cell differentiation. 41, 43, 44 To further complicate matters, stable induction of a T-cell fate by Delta is dependent on contact time 45 and density of ligands, with lower doses of Delta also promoting B-cell development. 46 Furthermore, the interaction of Notch with the different ligands can be modulated by Fringe proteins. 17 Overexpression in the thymus of Lunatic Fringe, which is thought to inhibit Notch activation by Jagged and facilitate interaction with Delta, 47 blocked T-cell commitment. 48 The downstream mechanisms by which a Notch signal is translated into a T-cell program are still largely unclear. The best known Notch target genes encode Hairy-Enhancer of Split (Hes)1 and Hes5 and Hes-related repressor protein (Herp), both basic-helix-loop-helix proteins that function as transcriptional repressors. 49, 50 Indeed overexpression of Hes1 and Hes5 in the BM partly inhibits B-cell development. 51 But although proliferation of early thymocytes is severely affected by Hes1 deficiency, 52, 53 thymocytes still develop in these mice. Also in human progenitors, transfection of Hes1 did not promote differentiation into the T-cell lineage. 54 Hes can therefore not be the sole target of Notch signaling in the thymus. By providing Notch signals to human progenitors in vitro, we could confirm HES1, NRARP and NOTCH1 itself as being genuine Notch target genes, but not DTX1 (the gene for Deltex-1) and PTCRA (the gene for pTa). 56 Furthermore, we identified previously unknown Notch targets, which are currently being tested functionally. We did not find any clues that Notch signaling can directly induce a T-cell fate, consistent with experiments of Taghon et al. 55 in which murine fetal liver progenitors were cultured on stromal cell line OP9 transfected with Delta1. This study showed that GATA3, TCF1 and PTCRA began to be expressed after three days of culture on OP9-Delta1, whereas high HES1 transcription was detected already after one day. These findings indicate that either Notch signaling induces T-cell genes in already more differentiated thymocytes, or Notch signaling stimulates the expression of other transcription factors, which in turn activate or repress lineage differentiation genes. In all, it is clear that although Notch is crucial for T-cell development, it is not the sole signal responsible for inducing T-cell lineage commitment. We have recently elaborated on this point elsewhere. 56 The Notch pathway is active in and necessary for T-cell development in the earliest thymocyte populations, 57, 58 but has also been implicated in later stages of T-cell development, mostly in the DN to DP transition. [59] [60] [61] [62] [63] Furthermore, mice in which Notch1 was deleted after the T/B-fate choice (Lck-cre Â Notch1 lox/lox ) show a complex phenotype which suggest that Notch1 contributes to both V to DJ rearrangement of the TCRB locus as well as to the physical elimination of cells that fail b-selection.
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There are conflicting data on a function of Notch signaling in promoting ab-lineage T-cell development at the expense of gd T cells [64] [65] [66] and in the selection between CD4 and CD8 SP thymocytes. 61, 62, [67] [68] [69] In light of the focus of this review we will not elaborate on these topics.
Wnt signaling in the thymus
Wnt genes encode a large family of secreted glycoproteins that regulate cell-to-cell interactions in many different cell types and 70 The central player in the Wnt-signaling cascade (depicted in Figure 3 ) is the cytoplasmic protein b-catenin. In the absence of Wnt signaling, b-catenin is present in a cytoplasmic 'destruction complex' and is continuously phosphorylated and degraded. When a Wnt protein binds to the receptor complex consisting of a member of the Frizzled (Fz) family of seven transmembrane proteins 71 and an LDL-receptorrelated protein (LRP5 or LRP6), 72 b-catenin is no longer phosphorylated, resulting in its accumulation and activation. 73 Deposphorylated b-catenin translocates to the nucleus, where it activates Tcf/Lef transcription factors, 74, 75 in thymocytes predominantly Tcf-1. 76, 77 Next to the canonical Wnt-signaling pathway, b-catenin-independent mechanisms exist (reviewed by Veeman et al.
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), but their implications for T-cell development have not been studied in detail.
In the thymus, Wnt proteins are mainly produced by the thymic epithelium, but to some extend also by the thymocytes. [79] [80] [81] [82] Conversely, Fz receptors are expressed primarily by the thymocytes, but also by stromal cells. 79 79 Recently, our group has shown that mainly DN1-3 thymocytes undergo Wnt signaling. 82 Retroviral transduction of fetal thymocytes with Wnt1 and Wnt4 increased their proliferation in culture. 79 Furthermore, blocking Wnt binding using soluble Fz receptors completely inhibited T-cell development at the DN and ISP stages. 79 The requirement of Wnt proteins for thymocytes was confirmed in vivo, by showing that mice deficient for both Wnt1 and Wnt4 have twofold reduced thymic cellularity. 83 This relatively mild reduction, combined with the fact that thymocyte subset distribution was normal in these mice, points out that different Wnt proteins are functionally redundant. The significance of Fz receptors in thymocytes was also indicated by the accelerated thymic atrophy observed in mice deficient for Fz9. 84 But again the mild defect emphasizes the involvement of multiple Fz receptors in the thymus.
Of the downstream Wnt-signaling components, Tcf-1 has been most extensively studied. Two different Tcf-1 mutant mice have been described, targeting either exon 5 (Tcf-1(V)) or exon 7 (Tcf-1(VII)). 85 In Tcf-1(V) mutant mice, a low level of a truncated yet functional Tcf-1 is still expressed, whereas the Tcf-1(VII) mutation abolishes the DNA-binding activity of Tcf-1 completely and is therefore regarded as a true Tcf-1 null mutant. Young Tcf-1-deficient mice have an incomplete block at the DN1, DN2 and ISP stages, whereas older mice display a complete block at the DN1 stage of thymocyte development. 85, 86 Although Lef-1 knockouts have normal T-cell development, 87 Lef-1/Tcf-1(V) double-deficient mice display a complete block in T-cell differentiation at the ISP stage, 88 showing the redundancy of these factors during thymocyte development.
The critical role of Tcf-1 in T-cell development may also lie in Wnt independent functions, for instance as transcriptional repressor. However, b-catenin binding to Tcf-1 is essential for thymocyte differentiation, as only Tcf isoforms which contain the N-terminal b-catenin binding domain could rescue the thymic defect in Tcf-1(VII) mice. 79, 89 The importance of b-catenin for T-cell development is controversial. Presence of b-catenin mRNA was detected in all thymoycte subsets. 80 Mice with b-catenin deleted in all T cells from DN3 onwards showed impaired T-cell development at the b-selection checkpoint, 90 but mice transplanted with HSCs in which b-catenin had been inducibly deleted, did not show in any thymic defect. 91 As possible explanation, redundancy between b-catenin and its homologue plakoglobin (g-catenin) has been suggested. Irradiated mice reconstituted with plakoglobin-deficient fetal liver cells did not display marked defects in T-cell development, only a slightly reduced survival of DN3 and DN4 thymocytes. 92 Nevertheless, mice overexpressing Axin, one of the components of the b-catenin destruction complex, exhibited reduced cell numbers and increased apoptosis in their thymus. 93 What is the function of Wnt signaling during T-cell development? The above-described studies of Tcf-1-deficient mice suggest that Wnt-signaling affects those stages of thymocyte differentiation where proliferation occurs. By using several methods to induce Wnt signaling in human CD34 þ thymocytes in combination with DNA microarrays, our group has identified Wnt target genes involved in proliferation and cell adhesion, but no T-cell-specific genes. 94 Wnt target genes were shown to include c-fos and c-jun, which were indeed absent in ISP thymocytes from Tcf-1-deficient mice. 94 In addition, transcription of T-cell-specific genes and rearrangement of the TCRB Signaling results in inhibition of GSK3b, which no longer can phosphorylate b-catenin, allowing accumulation of b-catenin and its translocation to the nucleus. b-catenin is targeted to the nucleus by Pygopus (Pygo) and Legless (LGS, Bcl-9). Binding of b-catenin to Tcf recruits histone acetylace CBP/p300 and Brg-1, a component of the SWI/SNF chromatin remodeling complex. Several factors can modulate Wnt signaling. For instance, interaction of Wnt with the receptor complex can be prevented by Dickkopf (Dkk), which binds to the LRP co-receptor. Binding of b-catenin to Tcf/Lef can be inhibited by the nuclear protein Chibby. 88 indicating that Wnt signaling does not directly induce a T-cell program. A role for Wnt proteins in inducing proliferation would also fit with the assumed function of Wnt signaling in stem cell self-renewal. 94, 95 Nevertheless, a role for Wnt signaling in differentiation cannot be excluded, although it is difficult to distinguish between proliferation and differentiation, as these processes are closely connected at this stage of T-cell development: massive proliferation of DN1 and 2 thymocyte subsets is essential before further development can proceed.
Notch and Wnt signaling in T-cell development and T-ALL
Similar to Notch signaling, additional roles for Wnt signaling have been reported in more mature stages of thymocyte development. In DP and SP subsets, Wnts probably block apoptosis rather than inducing proliferation. In thymocytes in which b-catenin was specifically activated from DN3 onwards, apoptosis of thymocytes with non-productive TCRB rearrangements was reduced. 96 Using the same approach but with lower levels of b-catenin, it was shown that constitutive b-catenin signaling enhanced the generation of mature thymocytes, interestingly preferentially of CD8 þ cells. 97 In accordance, deletion of b-catenin at the same stages impaired T-cell development at the b-selection checkpoint. 90 Tcf-1-deficient DP thymocytes were demonstrated to die more rapidly than wild-type cells, probably because of lower expression of antiapoptotic protein Bcl-x L . 89 Recently, it was shown that survival of pre-TCR þ thymocytes requires the b-catenin binding domain of Tcf-1. 92 
Notch in T-cell leukemia
Animal models have demonstrated a role for Notch in T-cell leukemias. 38, 98, 99 But although the t(7;9)(q34;q34.3) translocation, in which part of NOTCH1 is fused to the TCRB locus, was observed in rare cases of T-ALL already in 1991, 4 scientists only recently became aware of the tremendous importance of Notch1 for T-cell leukemogenesis in humans. Translocation (7;9) results in aberrant Notch1 expression (originally termed TAN1 onocogene) and is found in less than 1% of T-ALL. Weng et al. 100 discovered that over 50% of human T-ALL has activating mutations in Notch1. This important finding was the result of the observation that several T-ALL cell lines not harboring translocation (7;9), were sensitive to g-secretase inhibitors, resulting in a G 0 cell cycle arrest. Sequencing of the NOTCH1 gene in these cell lines resulted in identification of two types of mutations. These mutations occur either in the heterodimerization domain, causing an instable connection between the intracellular and extracellular domain, or in the negative regulatory PEST domain. Both mutations lead to increased levels of Notch-dependent transcription in reporter assays, presumably by increasing nuclear Notch1 levels. 100 The same types of mutations were found in a panel of primary T-ALL samples. Interestingly, these mutations were not associated with a particular subtype of T-ALL and occurred in all major subtypes of T-ALL, both in pediatric and adult patients. [100] [101] [102] Obviously, these findings have therapeutic implications, as g-secretase inhibitors could be used to treat T-ALL. However, given that Notch signaling also is implicated in many other developmental processes, including HSC self-renewal, such approaches need to be implemented with great caution.
It is incompletely understood why ectopic expression of IC-Notch leads to leukemia. Data in the mouse indicate that IC-Notch must cooperate with pre-TCR signaling to cause leukemia, as no T-cell development and T-ALL occurred when IC-Notch was over expressed in RAG À/À or SLP76 À/À BM. 103 At least T-cell-specific signals, for instance proliferative signals provided by preTCR signaling or other T-cell-specific proliferative signals (e.g. Wnt signaling to Tcf-1) are required to induce T-ALL. A recent report indicates that suppression of p53 by Notch may be the mechanism underlying deregulated T-cell proliferation, 104 whereas data in Notch3 transgenic mice suggest that activation of the nuclear factor-kappaB pathway by Notch may contribute to leukemogenesis. 105 
Wnt in T-cell leukemia
Unlike Notch signaling, deregulated Wnt signaling has been implicated in many forms of cancer. 106 Two types of mutations are found: inactivating (loss-of-function) mutations in the tumor suppressor genes Axin and APC, or activating (gain-of-function) mutations in b-catenin. Surprisingly, considering the unmistakable role of Wnt signaling during T-cell development, no involvement in T-ALL has been described thus far. Such a role is highly likely and may be caused by activating mutations in positive regulators of the Wnt-signaling pathways. Preliminary data from our laboratory indicate a fairly high frequency of T-ALL samples with accumulation of nuclear b-catenin, a hallmark of active Wnt signaling. We are currently exploring these findings in more detail.
Little by little, data are now accumulating to support a causative role for Wnt signaling in other hematopoietic malignancies. Perhaps the most striking evidence is provided by a seminal paper by Weissman et al. reporting involvement of Wnt signaling in the proliferation of chronic myelogenous leukemia (CML) stem cells. 107 Using a lentiviral TCF-GFP reporter, Weissman and colleagues provided evidence that Wnt signaling is activated in blast crises of CML. Other reports indicate involvement of Wnt signaling in AML, CLL and multiple myeloma. [108] [109] [110] [111] Studies on ALL are conspicuously absent, except for one report showing that the E2A-PBX1 fusion protein, involved in certain types of precursor B-ALL, activates the expression of Wnt16. 112 But studies with patient material and comparisons with normal precursor B cells (which undergo Wnt signaling) are lacking.
Interestingly, in apparent contrast to the fact that enhanced Wnt signaling causes cancer, Tcf-1 in absence of b-catenin also functions as a tumor suppressor. Tcf-1-deficient mice develop adenomas in the gut and mammary glands 113 and ageing animals develop a T-cell hyperplasia with all characteristics of human T-ALL (Baert et al., manuscript in preparation). Wnt5a hemizygous mice develop myeloid leukemias and B-cell lymphomas, 114 confirming a role for Wnt signaling in suppression of proliferation, presumably through the non-canonical Wnt pathway.
Notch and Wnt signaling: coalition or opposition?
It is generally thought that Wnt and Notch fulfill opposing functions in the thymus: Wnt in proliferation, Notch in differentiation, and that these processes are mutually exclusive. However, it may well be possible that Wnt and Notch signals combine forces to induce proliferation of the earliest thymocytes. Gain-of-function mutation in positive effectors in the Notch and Wnt pathway cause cancer, indicating that both may lead to increased proliferation.
Both Wnt 115 and Notch 116, 117 signaling have been implicated in HSC self-renewal. A recent report has suggested molecular cooperation between the Notch and Wnt pathways: Notch would keep HSCs in an undifferentiated state, allowing Wnt to induce proliferation. 117 Furthermore, Wnt signaling in HSCs upregulated Notch target genes, although no molecular explanation was provided. 117 A positive interaction between Wnt and Notch signaling has also been shown outside the hematopoietic system, 118-120 but other studies have indicated opposing functions for both pathways. For instance in skin, Notch signaling induces differentiation 121, 122 and acts as a tumor suppressor by inhibiting b-catenin-mediated signaling. 123 Nevertheless, it seems likely that in developing hematopoietic progenitor cells Wnt and Notch signaling induce proliferation and instruct cell fate decisions (Figure 4 ).
Conclusions
Increasing evidence confirms important roles for Notch and Wnt signaling in T-cell development. Both pathways may cooperate to induce massive proliferation of the earliest thymocytes; a key characteristic that may be exploited by malignantly transformed thymocytes. The frequent involvement of Notch signaling and the expected role of Wnt signaling in T-ALL, brings opportunities to develop novel therapeutic strategies. Figure 4 Hypothetical order of events during the earliest stages of T-cell development. The thymus-seeding cells (TSCs) encounter Delta ligands on the thymic stroma and start their development into the T-cell lineage. These early thymocytes rapidly upregulate Tcf1, which is subsequently activated by Wnt signals. Wnt target genes (e.g. c-fos and c-jun) and Notch target genes (e.g. Hes1) together induce massive proliferation of early thymocytes. After sufficient cell cycles, differentiation (e.g. rearrangements of the TCR genes) can occur. Differentiation of thymocytes is dependent on Notch signals and presumably on Wnt signals as well.
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